X4 Pharmaceuticals (XFOR)
(Delayed Data from NSDQ)
$1.17 USD
+0.04 (3.10%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.18 +0.02 (1.29%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -0.16 |
EPS Last Quarter | -0.10 |
Last EPS Surprise | 33.33% |
ABR | 1.33 |
Earnings ESP
|
-34.70% |
---|---|
Current Year | -0.47 |
Next Year | -0.46 |
EPS (TTM) | -0.60 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | 35.84M | 32.82M | 64.75M |
# of Estimates | NA | 3 | 6 | 6 |
High Estimate | NA | 105.22M | 115.89M | 163.10M |
Low Estimate | NA | 0.30M | 1.38M | 4.27M |
Year ago Sales | 0.00M | 0.00M | NA | 32.82M |
Year over Year Growth Est. | NA | NA | NA | 97.28% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.16 | -0.11 | -0.47 | -0.46 |
# of Estimates | 6 | 6 | 7 | 6 |
Most Recent Consensus | -0.22 | -0.20 | -0.08 | -0.37 |
High Estimate | -0.13 | 0.24 | -0.08 | -0.07 |
Low Estimate | -0.22 | -0.20 | -0.75 | -0.64 |
Year ago EPS | -0.16 | -0.33 | -0.57 | -0.47 |
Year over Year Growth Est. | 0.00% | 66.67% | 17.54% | 2.84% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 2 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 2 | 1 |
Down Last 60 Days | 1 | 2 | 4 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.16 | -0.11 | -0.47 | -0.46 |
7 Days Ago | -0.16 | -0.11 | -0.47 | -0.46 |
30 Days Ago | -0.15 | -0.09 | -0.45 | -0.44 |
60 Days Ago | -0.16 | -0.17 | -0.45 | -0.33 |
90 Days Ago | -0.16 | -0.17 | -0.45 | -0.33 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.22 | -0.20 | -0.33 | -0.37 |
Zacks Consensus Estimate | -0.16 | -0.11 | -0.47 | -0.46 |
Earnings ESP | -34.70% | -90.48% | 30.85% | 18.98% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.10 | -0.01 | -0.33 | -0.16 | NA |
Estimate | -0.15 | -0.15 | -0.17 | -0.20 | NA |
Difference | 0.05 | 0.14 | -0.16 | 0.04 | 0.02 |
Surprise | 33.33% | 93.33% | -94.12% | 20.00% | 13.14% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more